Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-07-2023 | Appendicitis | Case report

Pembrolizumab

Appendicitis : case report

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Almutairi A, et al. Appendicitis associated with pembrolizumab use: Adverse events-signal review. Pharmacoepidemiology and Drug Safety 31 (Suppl. 2): 232 abstr. 520, Sep 2022. Available from: URL: http://doi.org/10.1002/pds.5518 [abstract] Almutairi A, et al. Appendicitis associated with pembrolizumab use: Adverse events-signal review. Pharmacoepidemiology and Drug Safety 31 (Suppl. 2): 232 abstr. 520, Sep 2022. Available from: URL: http://​doi.​org/​10.​1002/​pds.​5518 [abstract]
Metadata
Title
Pembrolizumab
Appendicitis : case report
Publication date
01-07-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-43366-1

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Adalimumab

Case report

Metronidazole

Case report

Romosozumab